Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
Learn more about:
Related Clinical Trial
Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata
Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Tofacitnib for the Treatment of Alopecia Areata and Variants
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
Alopecia Areata Registry
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
Efalizumab in the Treatment of Alopecia, Phase II
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata